C-Jun Is Required for Nuclear Factor-κB-Dependent, LPS-Stimulated Fos-Related Antigen-1 Transcription in Alveolar Macrophages
Overview
Molecular Biology
Affiliations
Previously, we have reported that Fos-related antigen-1 (Fra-1) transcription factor promotes LPS-induced acute lung injury and mortality, and that LPS-induced Fra-1 expression in the lung occurs predominantly in alveolar macrophages. Nuclear factor-κB (NF-κB) and c-Jun transcription factors play key roles in modulating inflammatory and immune responses induced by infectious and non-infectious insults. Here, we report that NF-κB and c-Jun coregulate Fra-1 induction by LPS in alveolar macrophages and that this regulation occurs through both the NF-κB and the extracellular signal-regulated protein kinase (ERK) signaling pathways. Transient transfections with Fra-1 promoter-reporter constructs and inhibitor studies revealed that the transcriptional activation of Fra-1 by LPS in alveolar macrophages is mediated by NF-κB and ERK1/2 signaling. Importantly, chromatin immunoprecipitation assays revealed the recruitment of c-Jun and NF-κB to the endogenous Fra-1 promoter after LPS stimulation. We found that inhibition of ERK1/2 signaling reduced LPS-stimulated c-Jun and NF-κB recruitment to the promoter. Likewise, NF-κB inhibitor blocked LPS-induced NF-κB and c-Jun binding to the promoter. ERK1/2 inhibition had no effect on c-Jun activation but suppressed LPS-stimulated NF-κB phosphorylation. Finally, functional assays showed reduced levels of LPS-stimulated NF-κB regulated proinflammatory IL-1β and macrophage inflammatory protein-1α expression and increased antiinflammatory IL-10 expression in lung alveolar macrophages of Fra-1-null mice in vivo. Thus, our studies indicate that NF-κB and c-Jun coregulate LPS-induced Fra-1 transcription and that Fra-1 selectively modulates LPS-stimulated inflammatory cytokine expression in lung alveolar macrophages during inflammatory lung injury.
Lim P, Cervantes M, Pham L, Doherty S, Tufts A, Dubey D bioRxiv. 2024; .
PMID: 38826239 PMC: 11142172. DOI: 10.1101/2024.05.22.594428.
Wang X, Chen L, Chen X, Liu C, Qiu W, Guo K Exp Ther Med. 2023; 27(1):25.
PMID: 38125354 PMC: 10728954. DOI: 10.3892/etm.2023.12313.
Adir O, Sagi-Assif O, Meshel T, Ben-Menachem S, Pasmanik-Chor M, Hoon D Cancers (Basel). 2023; 15(20).
PMID: 37894348 PMC: 10605008. DOI: 10.3390/cancers15204979.
Chen Y, Dong Y, Zhang Z, Han J, Chen F, Tong X Brain Pathol. 2023; 33(1):e13113.
PMID: 36634215 PMC: 9836372. DOI: 10.1111/bpa.13113.
He Y, Zhou H, Chen L, Wang Y, Xie W, Xu Z Front Immunol. 2022; 13:954744.
PMID: 36032067 PMC: 9404335. DOI: 10.3389/fimmu.2022.954744.